Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets [Phase 1]

View source ↗

Summary

This clinical trial update describes the ongoing Phase 1 study of ABBV-525 tablets in adults with B-cell malignancies. The study evaluates adverse events and ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• ABBV-525

Snippet

Sponsor: AbbVie | Conditions: Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Status: RECRUITING